No Data
No Data
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Maxim Group Maintains Dermata Therapeutics(DRMA.US) With Buy Rating, Announces Target Price $6
Express News | Maxim Group Maintains Buy on Dermata Therapeutics, Lowers Price Target to $6
Dermata Therapeutics Analyst Ratings
Express News | Dermata Therapeutics Share Are Trading Higher. The Company Reported Q2 Financial Results
No Data